Sage Journals: Discover world-class research

Abstract

Objective: To characterize the prevalence of chronic obstructive pulmonary disease (COPD) among residential care facility (RCF) residents in the United States, and to compare patterns of hospital visits and comorbidities with residents without COPD. Method: Resident data from the 2010 National Survey of Residential Care Facilities were analyzed. Medical history and information on past-year hospital visits for 8,089 adult residents were obtained from interviews with RCF staff. Results: COPD prevalence was 12.4%. Compared with residents without COPD, emergency department visits or overnight hospital stays in the previous year were more prevalent (p < .05) among residents with COPD. Less than 3% of residents with COPD had no comorbidities. Arthritis, depression, congestive heart failure (CHF), diabetes, coronary heart disease, and asthma were more common (p < .05) among residents with COPD than those without COPD, but Alzheimer’s disease was less common. Discussion: COPD is associated with more emergency department visits, hospital stays, and comorbidities among RCF residents.

Keywords

chronic obstructive pulmonary disease hospitalization comorbidity residential facilities

Get full access to this article

View all access options for this article.

References

American Thoracic Society/European Respiratory Society Task Force. (2004). Standards for the diagnosis and management of patients with COPD. Retrieved from http://www.thoracic.org/clinical/copd-guidelines/index.php

Barr

R. G.

Celli

B. R.

Mannino

D. M.

Petty

Rennard

S. I.

Sciurba

F. C.

. . . Turino

G. M.

(2009). Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. American Journal of Medicine, 122, 348-355. doi:10.1016/j.amjmed.2008.09.042

Bourbeau

(2010). Preventing hospitalization for COPD exacerbations. Seminars in Respiratory and Critical Care Medicine, 31, 313-320. doi:10.1055/s-0030-1254071

Buckelew

S. P.

DeGood

D. E.

Roberts

K. D.

Butkovic

J. D.

MacKewn

A. S.

(2009). Awake EEG disregulation in good compared to poor sleepers. Applied Psychophysiology and Biofeedback, 34, 99-103. doi:10.1007/s10484-009-9080-7

Burns

D. M.

Lee

Shen

L. Z.

Gilpin

Tolley

H. D.

Vaughn

Shanks

T. G.

(1997). Cigarette smoking behavior in the United States. In Shopland

D. R.

Burns

D. M.

Garfinkle

Samet

J. M.

(Eds.), Changes in cigarette-related disease risks and their implication for prevention and control (pp. 13-112). Bethesda, MD: National Institutes of Health, National Cancer Institute.

Caffrey

Sengupta

Park-Lee

Moss

Rosenoff

Harris-Kojetin

(2012). Residents living in residential care facilities: United States, 2010 (NCHS Data Brief, No. 91, pp. 1-8). Hyattsville, MD: National Center for Health Statistics.

Cataldo

J. K.

Prochaska

J. J.

Glantz

S. A.

(2010). Cigarette smoking is a risk factor for Alzheimer’s Disease: An analysis controlling for tobacco industry affiliation. Journal of Alzheimer’s Disease, 19, 465-480. doi:10.3233/jad-2010-1240

Cazzola

Bettoncelli

Sessa

Cricelli

Biscione

(2010). Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respiration, 80, 112-119. doi:10.1159/000281880

Centers for Disease Control and Prevention. (2008). Smoking-attributable mortality, years of potential life lost, and productivity losses—United States, 2000-2004. Morbidity and Mortality Weekly Report, 57(45), 1226-1228.

10.

Centers for Disease Control and Prevention. (2012). Chronic obstructive pulmonary disease among adults—United States, 2011. Morbidity and Mortality Weekly Report, 61(46), 938-943.

11.

Chen

Huang

Guo

Mailman

R. B.

Park

Kamel

. . .Blair

(2010). Smoking duration, intensity, and risk of Parkinson disease. Neurology, 74, 878-884. doi:10.1212/WNL.0b013e3181d55f38

12.

Debanne

S. M.

Bielefeld

R. A.

Cheruvu

V. K.

Fritsch

Rowland

D. Y.

(2007). Alzheimer’s disease and smoking: Bias in cohort studies. Journal of Alzheimer’s Disease, 11, 313-321.

13.

Divo

Cote

de Torres

J. P.

Casanova

Marin

J. M.

Pinto-Plata

. . .Celli

(2012). Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine, 186, 155-161. doi:10.1164/rccm.201201-0034OC

14.

Echeverria

Zeitlin

(2012). Cotinine: A potential new therapeutic agent against Alzheimer’s disease. CNS Neuroscience & Therapeutics, 18, 517-523. doi:10.1111/j.1755-5949.2012.00317.x

15.

Feary

J. R.

Rodrigues

L. C.

Smith

C. J.

Hubbard

R. B.

Gibson

J. E.

(2010). Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: A comprehensive analysis using data from primary care. Thorax, 65, 956-962. doi:10.1136/thx.2009.128082

16.

Ferri

C. P.

West

Moriyama

T. S.

Acosta

Guerra

Huang

. . .Prince

M. J.

(2011). Tobacco use and dementia: Evidence from the 1066 dementia population-based surveys in Latin America, China and India. International Journal of Geriatric Psychiatry, 26, 1177-1185. doi:10.1002/gps.2661

17.

Ford

E. S.

Croft

J. B.

Mannino

D. M.

Wheaton

A. G.

Zhang

Giles

W. H.

(2013). COPD surveillance—United States, 1999-2011. Chest, 144, 284-305. doi:10.1378/chest.13-0809

18.

Garcia

A. M.

Ramon-Bou

Porta

(2010). Isolated and joint effects of tobacco and alcohol consumption on risk of Alzheimer’s disease. Journal of Alzheimer’s Disease, 20, 577-586. doi:10.3233/jad-2010-1399

19.

Garcia-Olmos

Alberquilla

Ayala

Garcia-Sagredo

Morales

Carmona

. . .Monteagudo

J. L.

(2013). Comorbidity in patients with chronic obstructive pulmonary disease in family practice: A cross sectional study. BMC Family Practice, 14, Article 11. doi:10.1186/1471-2296-14-11

20.

John

Lange

Hoernig

Witt

Anker

S. D.

(2006). Prevalence of anemia in chronic obstructive pulmonary disease: Comparison to other chronic diseases. International Journal of Cardiology, 111, 365-370. doi:10.1016/j.ijcard.2005.07.043

21.

Lindberg

Larsson

L. G.

Ronmark

Lundback

(2011). Co-morbidity in mild-to-moderate COPD: Comparison to normal and restrictive lung function. Journal of Chronic Obstructive Pulmonary Disease, 8, 421-428. doi:10.3109/15412555.2011.629858

22.

Liu

Guo

Park

Huang

Sinha

Freedman

N. D.

. . .Chen

(2012). Caffeine intake, smoking, and risk of Parkinson disease in men and women. American Journal of Epidemiology, 175, 1200-1207. doi:10.1093/aje/kwr451

23.

Lopez-Garcia

van Dam

R. M.

Willett

W. C.

Rimm

E. B.

Manson

J. E.

Stampfer

M. J.

. . .Hu

F. B.

(2006). Coffee consumption and coronary heart disease in men and women: A prospective cohort study. Circulation, 113, 2045-2053. doi:10.1161/circulationaha.105.598664

24.

Mapel

D. W.

Hurley

J. S.

Frost

F. J.

Petersen

H. V.

Picchi

M. A.

Coultas

D. B.

(2000). Health care utilization in chronic obstructive pulmonary disease: A case-control study in a health maintenance organization. Archives of Internal Medicine, 160, 2653-2658.

25.

Marsh

S. E.

Travers

Weatherall

Williams

M. V.

Aldington

Shirtcliffe

P. M.

. . .Beasley

R. W.

(2008). Proportional classifications of COPD phenotypes. Thorax, 63, 761-767. doi:10.1136/thx.2007.089193

26.

Moss

A. J.

Harris-Kojetin

L. D.

Sengupta

Park-Lee

Caffrey

Rosenoff

. . .Greene

A. M.

(2011). Design and operation of the 2010 National Survey of Residential Care Facilities (Vital and Health Statistics, Series 1, No. 54). Retrieved from http://www.cdc.gov/nchs/data/series/sr_01/sr01_054.pdf

27.

Nazir

S. A.

Erbland

M. L.

(2009). Chronic obstructive pulmonary disease: An update on diagnosis and management issues in older adults. Drugs Aging, 26, 813-831. doi:10.2165/11316760-000000000-00000

28.

Nettleton

J. A.

Follis

J. L.

Schabath

M. B.

(2009). Coffee intake, smoking, and pulmonary function in the Atherosclerosis Risk in Communities Study. American Journal of Epidemiology, 169, 1445-1453. doi:10.1093/aje/kwp068

29.

Ohar

Fromer

Donohue

J. F.

(2011). Reconsidering sex-based stereotypes of COPD. Primary Care Respiratory Journal, 20, 370-378. doi:10.4104/pcrj.2011.00070

30.

Quik

Perez

X. A.

Bordia

(2012). Nicotine as a potential neuroprotective agent for Parkinson’s disease. Movement Disorders, 27, 947-957. doi:10.1002/mds.25028

31.

Schnell

Weiss

C. O.

Lee

Krishnan

J. A.

Leff

Wolff

J. L.

Boyd

(2012). The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: A cross-sectional study using data from NHANES 1999-2008. BMC Pulmonary Medicine, 12, Article 26. doi:10.1186/1471-2466-12-26

32.

Schoenborn

C. A.

(2004). Marital status and health: United States, 1999-2002 (Advance Data, No. 351, pp. 1-32). Retrieved from http://www.cdc.gov/nchs/data/ad/ad351.pdf

33.

Sin

D. D.

Man

S. F.

(2005). Chronic obstructive pulmonary disease: A novel risk factor for cardiovascular disease. Canadian Journal of Physiology and Pharmacology, 83, 8-13. doi:10.1139/y04-116

34.

Soriano

J. B.

Visick

G. T.

Muellerova

Payvandi

Hansell

A. L.

(2005). Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest, 128, 2099-2107. doi:10.1378/chest.128.4.2099

35.

Tsai

C. L.

Clark

Cydulka

R. K.

Rowe

B. H.

Camargo

C. A.

Jr. (2007). Factors associated with hospital admission among emergency department patients with chronic obstructive pulmonary disease exacerbation. Academic Emergency Medicine, 14, 6-14. doi:10.1197/j.aem.2006.07.034

36.

Wirdefeldt

Adami

H. O.

Cole

Trichopoulos

Mandel

(2011). Epidemiology and etiology of Parkinson’s disease: A review of the evidence. European Journal of Epidemiology, 26(Suppl. 1), 1-58. doi:10.1007/s10654-011-9581-6

Chronic Obstructive Pulmonary Disease,Hospital Visits,and Comorbidities

Abstract

Keywords

Get full access to this article

References